Definium Therapeutics, Inc. (DFTX)
40.98
-2.84
(-6.48%)
USD |
NASDAQ |
Aug 28, 16:00
41.00
+0.02
(+0.05%)
After-Hours: 20:00
Definium Therapeutics Market Cap : 5.506B for Aug. 28, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 28, 2026 | 5.506B |
| August 27, 2026 | 5.888B |
| August 26, 2026 | 5.881B |
| August 25, 2026 | 6.021B |
| August 24, 2026 | 5.814B |
| August 21, 2026 | 6.034B |
| August 20, 2026 | 6.100B |
| August 19, 2026 | 6.157B |
| August 18, 2026 | 6.205B |
| August 17, 2026 | 6.081B |
| August 14, 2026 | 5.728B |
| August 13, 2026 | 5.899B |
| August 12, 2026 | 5.750B |
| August 11, 2026 | 5.497B |
| August 10, 2026 | 6.067B |
| August 07, 2026 | 6.200B |
| August 06, 2026 | 6.200B |
| August 05, 2026 | 5.965B |
| August 04, 2026 | 5.686B |
| August 03, 2026 | 4.348B |
| July 31, 2026 | 4.528B |
| July 30, 2026 | 4.629B |
| July 29, 2026 | 4.387B |
| July 28, 2026 | 4.366B |
| July 27, 2026 | 4.437B |
| Date | Value |
|---|---|
| July 24, 2026 | 4.492B |
| July 23, 2026 | 4.467B |
| July 22, 2026 | 4.544B |
| July 21, 2026 | 4.690B |
| July 20, 2026 | 4.453B |
| July 17, 2026 | 4.608B |
| July 16, 2026 | 4.588B |
| July 15, 2026 | 4.751B |
| July 14, 2026 | 4.784B |
| July 13, 2026 | 4.542B |
| July 10, 2026 | 4.897B |
| July 09, 2026 | 5.041B |
| July 08, 2026 | 4.715B |
| July 07, 2026 | 4.628B |
| July 06, 2026 | 4.612B |
| July 02, 2026 | 4.598B |
| July 01, 2026 | 4.516B |
| June 30, 2026 | 4.894B |
| June 29, 2026 | 4.843B |
| June 26, 2026 | 4.677B |
| June 25, 2026 | 4.660B |
| June 24, 2026 | 4.383B |
| June 23, 2026 | 3.764B |
| June 22, 2026 | 3.815B |
| June 18, 2026 | 2.547B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Cocrystal Pharma, Inc. | 15.17M |
| CNBX Pharmaceuticals, Inc. | 0.2066M |
| GB Sciences, Inc. | 0.1221M |
| Arvinas, Inc. | 599.45M |
| Fulcrum Therapeutics, Inc. | 293.70M |
Market Cap Related Metrics
| PEG Ratio | -0.0883 |
| Price to Book Value | 5.994 |
| Price | 40.98 |
| Earnings Yield | -8.39% |
| PEGY Ratio | -0.0883 |